Previous Page  100 / 119 Next Page
Information
Show Menu
Previous Page 100 / 119 Next Page
Page Background

Emerging Concepts in Ion Channel Biophysics

Poster Abstracts

95 

15-POS

Board 15

Minocycline Inhibits ASIC Currents in Dorsal Root Ganglion Neurons by a Selective

Action on the ASIC1a Channel Subunit

Caba Sánchez Laura Cecilia

1

, Soto Eguibar Enrique

1

, Vega Y Saenz de Miera Maria del

Rosario

1

,

Félix Grijalva Ricardo

2

.

1

Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla, Puebla, México.

2

Departamento de Biología Celular, Centro de Investigación y Estudios Avanzado del Instituto

Politécnico Nacional (CINVESTAV-IPN), CDMX, México

Acid Sensing Ion Channels (ASIC) are proton-activated Na+ channels expressed in the nervous

system, where they are involved in learning, fear behavior, neurodegeneration, nociception,

mechanoreception, chemoreception, ischemia, epilepsy, inflammation, among others. Thus, the

discovery of pharmacological agents targeting ASICs has high therapeutic potential.

Minocycline is a semisynthetic antibiotic of the tetracycline family that has neuroprotective

properties, in processes in which ASICs have been involved (such as neurodegeneration,

nociception, and inflammation), which led us to postulate the ASICs as a minocycline target. As

we hypothesized, whole cell voltage clamp recordings from isolated dorsal root ganglion (DRG)

neurons from the rat, shown that minocycline inhibits the peak amplitude of proton gated current

(ASIC) neurons in a dose-dependent manner (IC50 ~ 100 μM). In heterologous expression

system CHO-cells, minocycline selectively inhibits the ASIC1a currents without significant

inhibitory effects in ASIC2a, ASIC1b or ASIC3 currents. Molecular anchor analysis (in-silico

analyses) suggests the “acid pocket” and the “central vestibule” as putative minocycline bindings

sites in the chicken ASIC1a channel. These results demonstrate the inhibitory action of

minocycline on the ASIC currents, contributing to account for the neuroprotective action of

minocycline, and opening a venue for research of tetracycline derived molecules as potentially

relevant drugs to manipulate ASIC currents, and to improve neuroprotective therapeutic

armamentarium.